The Non-Invasive Fat Reduction Market Size was valued at USD 1.39 billion in 2023 and is expected to reach USD 4.67 billion by 2031, and grow at a CAGR of 16.3% over the forecast period 2024-2031.
Non-invasive fat reduction is a noninvasive therapy that breaks down fat cells selectively in specific regions to reduce the size of fat tissue stores. Overweight is on the rise worldwide, particularly in North America. Being overweight is on the rise, and those who are affected are becoming increasingly concerned about their health. As a result, public awareness of the negative consequences of obesity is growing. As a result of these growing concerns, the demand for minimally invasive and non-invasive fat removal methods is expanding. These elements have added to the market's general development.
Get more information on Non-Invasive Fat Reduction Market - Request Sample Report
Besides, non-invasive fat reduction gadget is costly, hence the technique's expense ascends also. Moreover, while these lasers are protected to utilize, they might leave careful markings on the skin after a medical procedure. Subsequently, these variables are blocking market extension.
DRIVERS
More demand for body shaping devices.
Demand for body contouring
Non-surgical fat reduction procedures adoption
RESTRAINTS
High Cost
Supply chain activities have been restricted
Lack of skill and technical knowledge.
OPPORTUNITIES
Focus on launching new product with advance technologies
Expanding Regional presence
CHALLENGES
Government police
environmental worries are rising
The COVID-19 epidemic has had a significant impact on the whole market. However, many aesthetic specialists believe that the pandemic will certainly accelerate the aesthetic business as a whole. The number of future appointments and consultations for various skin treatments has increased at many dermatological clinics, which is projected to support market growth. These treatments should be performed by qualified experts who are actually capable.
By Technologies: Cryolipolysis is a non-invasive procedure that uses freezing temperatures to freeze and destroy fat in the targeted location, which is then drained out of the body by metabolic processes over the course of two to six months.
Consumers are likely for a low-risk procedure that provides immediate and long-term results. Demand for cryo lipolysis is predicted to increase because it is more economical, has relatively common problems such as transient soreness, has no downtime, and a number of campaigns have been undertaken by various major parties to raise knowledge about the device's safety and advantages.
By End Use: Hospital facilities are well equipped with high-tech, fat reduction devices, skilled practitioners, and the required infrastructure to carry out such procedures; also, when the treatment is conducted in a hospital, there is a sense of confidence and reliability. The accreditation of a hospital is an important feature that has a beneficial impact on a patient's decision to undergo cosmetic operations. The multispecialty clinic category is expected to increase significantly throughout the projection period, as it meets all of the patients' demands in one convenient place, with procedural flexibility and the availability of qualified practitioners. In the future years, the market as a whole is expected to have extremely high demand and strong growth potential, resulting in total market expansion and greater revenue.
By Technology Type
Low-Level Lasers
Ultrasound
Cry lipolysis
Others
By End-Use Type
Hospitals
Multispecialty Clinics
Stand Alone Practices
.png)
Need any customization research on Non-Invasive Fat Reduction Market - Enquiry Now
The Non-Invasive Fat Reduction market was split evenly between North America, Europe, and Asia Pacific. Among the few factors expected to contribute to the market's growth are an increase in the number of well-established Non-Invasive Fat Reduction companies and research institutes in the United States and Canada, a large number of ongoing research studies, and the overall growth of the healthcare sector on a global scale. The increased elderly population, increasing surgical procedures, and the availability of established healthcare infrastructure all contribute to regional market growth. One of the key reasons for the increased demand for Non-Invasive Fat Reduction techniques and technologies among academic and research institutions is the fact that they are less invasive.
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
South Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
The Major key market players are as follows - Fosun Pharmaceuticals Co. Ltd, Zeltiq Aesthetics, BTL Industries, Lynton Lasers Ltd., Cutera Inc, Venus Concept, Cynosure, Candela Corporation, and Other Players.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 1.39 Billion |
| Market Size by 2031 | US$ 4.67 Billion |
| CAGR | CAGR of 16.3% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Technology Type (Low-Level Lasers, Ultrasound, Cry lipolysis, Others) • By End-Use Type (Hospitals, Multispecialty Clinics, Stand Alone Practices) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Fosun Pharmaceuticals Co. Ltd, Zeltiq Aesthetics, BTL Industries, Lynton Lasers Ltd., Cutera Inc, Venus Concept, Cynosure, Candela Corporation |
| DRIVERS | • More demand for body shaping devices. • Demand for body contouring • Non-surgical fat reduction procedures adoption |
| Restraints | • High Cost • Supply chain activities have been restricted • Lack of skill and technical knowledge. |
Ans: The Non-Invasive Fat Reduction Market Size was valued at USD 1.39 billion in 2023.
Ans: The USD 4.67 billion is the expected market size in 2031.
Ans: Major players in the market are Fosun Pharmaceuticals Co. Ltd, Zeltiq Aesthetics, BTL Industries, Lynton Lasers Ltd., Cutera Inc, Venus Concept, Cynosure, Candela Corporation, and others in final report.
Supply chain activities have been restricted
Lack of skill and technical knowledge.
Ans: The forecast period of Non-Invasive Fat Reduction Market is 2024-2031.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Non-invasive fat reduction market Segmentation, by Technology Type
8.1 Low-Level Lasers
8.2 Ultrasound
8.3 Cry lipolysis
8.4 Others
9. Non-invasive fat reduction market Segmentation, by End-Use Type
9.1 Hospitals
9.2 Multispecialty Clinics
9.3 Stand Alone Practices
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 USA
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 The Netherlands
10.3.7 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 South Korea
10.4.3 China
10.4.4 India
10.4.5 Australia
10.4.6 Rest of Asia-Pacific
10.5 The Middle East & Africa
10.5.1 Israel
10.5.2 UAE
10.5.3 South Africa
10.5.4 Rest
10.6 Latin America
10.6.1 Brazil
10.6.2 Argentina
10.6.3 Rest of Latin America
11. Company Profiles
11.1 Fosun Pharmaceuticals Co. Ltd
11.1.1 Financial
11.1.2 Products/ Services Offered
11.1.3 SWOT Analysis
11.1.4 The SNS view
11.2 Zeltiq Aesthetics
11.3 BTL Industries
11.4 Lynton Lasers Ltd.
11.5Cutera Inc
11.6 Venus Concept
11.7 Cynosure
11.8 Candela Corporation.
12. Competitive Landscape
12.1 Competitive Benchmark
12.2 Market Share Analysis
12.3 Recent Developments
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Exosome Diagnostics & Therapeutics Market was USD 36.0 million in 2023 and will reach USD 2962.8 Mn by 2032, growing at a CAGR of 63.25% by 2024-2032.
The Over-The-Counter (OTC) Drugs market was USD 87.32 bn in 2023 and is projected to grow at a CAGR of 6.18%, reaching USD 149.72 bn by 2032.
The Leukemia Therapeutics Market size was USD 16 Billion in 2023 and is expected to Reach USD 27.28 Billion by 2031 and grow at a CAGR of 6.9% over the forecast period of 2024-2031.
The Ophthalmology PACS Market Size was esteemed at USD 152.50 million of every 2023, and is expected to arrive at USD 289.94 million by 2032, and develop at a CAGR of 7.4% over the gauge period 2024-2032.
The Gene Therapy Market Size was valued at USD 9.2 Billion in 2023, and is expected to reach USD 54.39 Billion by 2032, and grow at a CAGR of 23.12%.
The Glioblastoma Multiforme Treatment Market size was valued at USD 2.69 billion in 2023 and is expected to reach at USD 5.68 billion by 2031 and grow at a CAGR of 9.8% over the forecast period of 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
